Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: REJUVENATE BIO INC.
Awarding agency: Department of Defense / Defense Contract Management Agency
Funding agency: Department of Defense / U.S. Special Operations Command
Period of performance: 2019-03-04 to 2021-08-20
Current total value of award: $2220133
Description: STTR PH II TOPIC&PROTOTYPE DEVELOPMENT - HUMAN PERFORMANCE OPTIMIZATION